PlainRecalls
FDA Drug Moderate Class II Terminated

Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml), 5 mL per syringe, Rx Only, SYRINGE FOR IM INJECTION, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178, Barcode 0544650505

Reported: January 20, 2021 Initiated: March 19, 2020 #D-0226-2021

Product Description

Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml), 5 mL per syringe, Rx Only, SYRINGE FOR IM INJECTION, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178, Barcode 0544650505

Reason for Recall

Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.

Details

Recalling Firm
Edge Pharma, LLC
Units Affected
71 syringes
Distribution
Nationwide
Location
Colchester, VT

Frequently Asked Questions

What product was recalled?
Methotrexate, USP Sterile Solution for Injection, Preservative Free 125mg/5ml (25mg/ml), 5 mL per syringe, Rx Only, SYRINGE FOR IM INJECTION, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178, Barcode 0544650505. Recalled by Edge Pharma, LLC. Units affected: 71 syringes.
Why was this product recalled?
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 20, 2021. Severity: Moderate. Recall number: D-0226-2021.